Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional studyGaku Yamamichi, Taigo Kato, Satoru Yumiba, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in JapanTaigo Kato, Satoru Yumiba, Wataru Nakata, et al.
The Prostate|August 29, 2017
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimensTakuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2020
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)Shin-Ichi Fukumoto, Satoshi Oizumi, Masao Harada, et al.
Anticancer Research|September 4, 2020
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell CarcinomaTaigo Kato, Eisuke Tomiyama, Yoko Koh, et al.
International Journal of Clinical Oncology|July 21, 2018
A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)Taichi Takashina, Hajime Asahina, Satoshi Oizumi, et al.
Biomarker Research|November 26, 2024
GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironmentGaku Yamamichi, Taigo Kato, Noriaki Arakawa, et al.
Cancer Science|March 15, 2021
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkersEisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
International Journal of Clinical Oncology|July 13, 2022
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective studyTaigo Kato, Kazutoshi Fujita, Takafumi Minami, et al.
Pageof 6